Tuesday, 6 May 2014

50th Anniversary of LAL Reagent Development

The American Pharmaceutical Review is running a special feature marking the “50th Anniversary of LAL Reagent Development”. The feature takes the form of a roundtable discussion about the importance of LAL and its future development.

The participants are:
  • John Dubczak, General Manager, Charles River, Endotoxin and Microbial Detection
  • Tim Sandle, Ph.D., Head of Microbiology, Bio Products Laboratory Ltd.
  • Lakiya Wimbish, Product Manager, QC Testing Solutions Lonza Pharma&Biotech–Bioscience Solutions. 

The article appears in the March 2014 edition (volume 17, issue 2).

Posted by Tim Sandle

Special offers